June 3, 2021, Video: "Do corporate valuations make sense? What are the implications of Biden’s tax proposals? And how did the pandemic…
June 10, 2021, Paper: "This article examines the evolution of Indian pharmaceutical manufacturer Cipla toward producing drugs that met the…
M-RCBG Associate Working Paper No. 170
Congress at a Climate Crossroads: Legislative Pathways for Decarbonization in the United States…
M-RCBG Associate Working Paper No. 168
The Uncertain Cost of Uncertainty: An Inquiry into Exchange Rate Volatility and Bilateral Trade…
June 1, 2021, Paper: "Since the Global Crisis, the size of central bank balance sheets has grown significantly. Traditional goals of price…
We examine how much of the overall decline in employment between the beginning of 2020 and 2021 can be explained by excess job loss among…
While national governments pledged to reduce their greenhouse gas emissions under the Paris Agreement, delivering on these aims will…
Regulatory review of new medicines is often viewed as a hindrance to innovation by increasing the hurdle to bring products to market.…